Simulations Plus, Inc.SLP was a big mover last session, as the company saw its shares rise nearly 6% on the day. Shares gained after the company reported higher earnings and revenues for the third ...

A “Validated” column in the DDI perpetrator table to clearly identify the values that have been validated by our DDI experts for use in simulations Dr. Michael Bolger, Founding Scientist of Simulation ...

Simulations Plus, Inc. (SLP) reported third-quarter fiscal 2025 adjusted earnings of 45 cents per share, which expanded 66.7% year over year. The figure also surpassed the Zacks Consensus Estimate of ...

The company's recent performance was broadly in line with expectations; however, if its guidance is accurate, revenue and profitability could rise this fiscal year. For its fiscal fourth quarter of ...

Simulations Plus faces soft revenue growth in the short term, due largely to macro conditions. The negatives appear to have been priced in, though, after a period of significant share price declines.

Polen Capital Management, a value-driven, concentrated, long-term investment management firm, published its ‘Polen U.S. Small Company Growth’ fourth-quarter 2020 Investor Letter – a copy of which can ...

SUMMARY Simulations Plus(NASDAQ:SLP) reported mixed operational results for Q3 FY2025, as inorganic revenue gains from acquisitions were offset by organic decline and profitability was burdened by a ...

Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly net return ...

Simulations Plus, Inc. is a company that develops software for drug discovery and development using artificial intelligence and machine learning technology. SLP has seen what was very impressive ...

On Wednesday, 10 September 2025, Simulations Plus (NASDAQ:SLP) presented at the Morgan Stanley 23rd Annual Global Healthcare Conference, celebrating its 30th anniversary. CEO Sean O’Connor highlighted ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods ...